Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

9,078 total articles

FCAC fines Bank of Montreal $4M over undisclosed banking program fees

FCAC fines Bank of Montreal $4M over undisclosed banking program fees

Canada’s Financial Consumer Agency (FCAC) has imposed a $4 million administrative penalty on the Bank of Montreal for breaches of the Bank Act’s consumer provisions tied to inaccurate fee disclosure. The lapses, occurring mainly from 2010 to 2024, affected specific discounted programs and resulted in erroneous fees for 101,091 customers, many of wh…

Daiwa Lifts Ratings on Mastercard and Visa After Strong Quarterly Results

Daiwa Lifts Ratings on Mastercard and Visa After Strong Quarterly Results

Daiwa Capital Markets upgraded both Mastercard and Visa to Outperform following recent earnings reports. The brokerage highlighted better-than-expected revenue and earnings trends, encouraging medium-term guidance, and specific commercial developments that reduce uncertainty. For Mastercard, stronger revenue growth, EPS expansion and a renewal with…

Arko Petroleum Files for Up to $210 Million IPO, Nears $1 Billion Valuation

Arko Petroleum Files for Up to $210 Million IPO, Nears $1 Billion Valuation

Arko Petroleum Corp., the wholesale fuel arm of convenience store operator Arko Corp., has filed to raise as much as $210 million in an initial public offering that could value the business at close to $1 billion. The company said it will offer 10.5 million shares priced between $18 and $20 apiece and plans to trade on Nasdaq under the symbol APC. …

Relay Therapeutics Shares Rise After FDA Grants Breakthrough Therapy Status for Zovegalisib-Fulvestrant Regimen

Relay Therapeutics Shares Rise After FDA Grants Breakthrough Therapy Status for Zovegalisib-Fulvestrant Regimen

Relay Therapeutics Inc. (NASDAQ: RLAY) saw its stock climb in premarket trading after the U.S. Food and Drug Administration awarded Breakthrough Therapy designation to zovegalisib in combination with fulvestrant for a defined breast cancer population. The decision was supported by Phase 1/2 ReDiscover trial data and covers adults with PIK3CA-mutant…